Literature DB >> 2827351

Arachidonate lipoxygenase products and renal allograft rejection in dogs.

M J Mangino1, C B Anderson, K Deschryver, J Turk.   

Abstract

The production of 12-hydroxyeicosatetraenoic acid (12-HETE) and leukotriene B4 (LTB4) was studied in renal tissue obtained from renal allografts and normal kidneys of nonimmunosuppressed dogs that had undergone unilateral renal allotransplantation. We have shown that allografted renal cortex undergoing rejection synthesizes significantly greater quantities of 12-HETE than normal or autotransplanted control renal cortex. There was no significant increase in 12-HETE production by allografted medulla undergoing rejection. Production of LTB4 was significantly greater in the rejecting renal cortex compared to control renal cortex but was not different in the rejecting compared to normal renal medulla. Production of 12-HETE and LTB4 was significantly inhibited by the lipoxygenase-cyclooxygenase inhibitor BW755C, suggesting that production of these compounds was enzyme catalyzed. Histologic examination of renal tissue undergoing rejecting revealed varying degrees of tissue destruction and cellular infiltration. These histologic parameters correlated with the magnitude of 12-HETE production in the allografts. Our findings therefore indicate that arachidonate lipoxygenase products are generated in increased amounts by renal cortical tissue undergoing rejection and suggest that these products may be involved in the rejection process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827351     DOI: 10.1097/00007890-198712000-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Lipoxygenase products in the urine correlate with renal function and body temperature but not with acute transplant rejection.

Authors:  Stephan W Reinhold; Thomas Scherl; Benjamin Stölcker; Tobias Bergler; Ute Hoffmann; Christian Weingart; Miriam C Banas; Dmitrij Kollins; Martin C Kammerl; Bernd Krüger; Bernhard Kaess; Bernhard K Krämer; Bernhard Banas
Journal:  Lipids       Date:  2012-12-29       Impact factor: 1.880

2.  Effect of renal replacement therapy on selected arachidonic acid derivatives concentration.

Authors:  Elżbieta Cecerska-Heryć; Rafał Heryć; Magda Wiśniewska; Natalia Serwin; Bartłomiej Grygorcewicz; Barbara Dołęgowska
Journal:  BMC Nephrol       Date:  2020-09-11       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.